2019 / 03

Next Paper
DOI: 10.24075/brsmu.2019.040

CLINICAL CASE

Detection of chromosomal rearrangements in the short arms of chromosomes 4 and 12 as an example of a whole-genome approach to noninvasive prenatal testing

Goltsov AYu, Mukosey IS, Kochetkova TO, Shubina J, Kuznetsova MV, Stupko OK, Barkov IYu, Rebrikov DV, Trofimov DYu
About authors

Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

Correspondence should be addressed: Andrey Yu. Goltsov
Akademika Oparina 4, Moscow, 117997; moc.liamg@vostlog.yerdna

About paper

Author contribution: Goltsov AYu, Mukosey IS — noninvasive prenatal screening; Shubina J, Kochetkova TO — data analysis; Kuznetsova MV — microarray analysis; Stupko OK — cytogenetic chromosome analysis; Barkov IYu — genetic counseling; Trofimov DYu, Rebrikov DV — manuscript writing, study supervision.

Received: 2019-05-24 Accepted: 2019-06-08 Published online: 2019-06-15
|
  1. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. American journal of obstetrics and gynecology. 2011; 204 (3): 205–e1.
  2. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenatal diagnosis. 1997; 17 (9): 821–9.
  3. Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: Clinical experience from 146 958 pregnancies. Ultrasound Obstet. Gynecol. 2015; 45 (5): 530–8.
  4. Hartwig TS, Ambye L, Sørensen S, Jørgensen FS. Discordant non-invasive prenatal testing (NIPT) — a systematic review. Prenat Diagn. 2017; 37 (6): 527–39.
  5. Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn. 2013; 33 (7): 667–74.
  6. Sukhikh GT, Karetnikova NA, Baranova EE, Shubina E, Korostin DO, Ekimov A, et al. Noninvasive prenatal diagnosis of aneuploidies by next- generation sequencing (ngs) in a group of high-risk women. Obstetrics and Gynecology. 2015; (4): 5–10.
  7. Noninvasive prenatal DNA-scrining fetal aneuploidy in maternal blood by next-generation sequencing (ngs) method. Clinical recommendation. Obstetrics and Gynecology. 2016; (6): 1–22.
  8. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010; 2 (61): 61–91.
  9. Fiorentino F, Bono S, Pizzuti F, Mariano M, Polverari A, Duca S, et al. The importance of determining the limit of detection of non invasive prenatal testing methods. Prenat Diagn. 2016; 36 (4): 304–11.
  10. Juneau K, Bogard PE, Huang S, Mohseni M, Wang ET, Ryvkin P, et al. Microarray-Based Cell-Free DNA Analysis Improves Noninvasive Prenatal Testing. Fetal Diagn Ther. 2014; 36 (4): 282–6.
  11. Wang J-C, Sahoo T, Schonberg S, Kopita K, Ross L, Patek K, et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med. 2015; 17 (3): 234–6.
  12. Ma J, Cram DS, Zhang J, Shang L, Yang H, Pan H. Birth of a child with trisomy 9 mosaicism syndrome associated with paternal isodisomy 9: case of a positive noninvasive prenatal test result unconfirmed by invasive prenatal diagnosis. Mol Cytogenet. 2015; (8): 44.